AH
AHG.US Akso Health Group ADR
- Market cap
- USD 1.15B
- P/E
- -
- P/B
- 6.37x
- ROE
- -41.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is AHG.US undervalued?
Graham numberThe Graham number of Akso Health Group ADR cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Akso Health Group ADR fundamental analysis
No fundamental analysis for Akso Health Group ADR yet.
Akso Health Group ADR stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Akso Health Group ADR
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In add…
Full company profileAkso Health Group ADR financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Akso Health Group ADR annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 22.9M | 107M | 61.3M | 6.91M | 1.75M | 6.31M | 13.2M | 2.41M | 14.8M | 13.8M | 13.7M |
| Gross Profit | 17.8M | 98.8M | 53.9M | 6.91M | 1.21M | 916K | 1.27M | 122K | -282K | -11.3K | -1.27M |
| Operating Income | 9.91M | 75.9M | 5.10M | -48.1M | -27.1M | -15.1M | -14.3M | -8.64M | -166M | -4.00M | -38.5M |
| EBITDA | 10.0M | 76.0M | 5.50M | -44.3M | -28.9M | -15.9M | -14.2M | -8.64M | -1.77M | -1.63M | -2.83M |
| Net Income | 8.57M | 65.5M | 5.53M | -71.2M | -34.8M | -16.8M | -1.36M | -9.46M | -135M | -18.7M | -74.7M |
| EPS | 1.61 | 12 | 0.94 | -13 | -6.42 | -0.85 | -0.18 | -0.40 | -0.47 | -0.03 | -0.10 |
| Balance Sheet | |||||||||||
| Total Assets | 28.4M | 164M | 173M | 80.5M | 31.7M | 50.7M | 20.5M | 142M | 215M | 190M | 190M |
| Total Liabilities | 4.88M | 23.8M | 46.8M | 32.4M | 14.4M | 38.4M | 11.6M | 3.59M | 15.8M | 8.71M | 8.71M |
| Shareholders' Equity | 23.5M | 140M | 127M | 48.1M | 17.3M | 12.3M | 8.73M | 138M | 199M | 181M | 181M |
| Cash & Short-term Investments | 19.2M | 133M | 57.4M | 6.67M | 15.1M | 21.9M | 7.92M | 85.2M | 176M | 171K | 171K |
| Total Debt | - | - | 20.0M | 20.8M | 10.0M | - | 9.69M | 2.00M | 81.7K | 376K | 376K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.19M | 87.7M | -1.73M | -55.9M | 10.1M | -8.63M | -3.25M | 1.35M | 1.18M | -12.8M | -51.2M |
| Capital Expenditure | 288K | 456K | 945K | 315K | 4.86K | 4.86K | 4.86K | 0.00 | 154K | 176M | 6.55K |
| Free Cash Flow | 7.90M | 87.3M | -2.68M | -56.2M | 10.1M | -8.63M | -3.25M | 1.35M | 1.02M | -188M | -51.2M |
| Ratios | |||||||||||
| ROE | 36.5% | 46.8% | 4.4% | -148.0% | -201.6% | -137.2% | -15.6% | -6.8% | -67.8% | -10.3% | -41.3% |
| ROA | 30.2% | 40.0% | 3.2% | -88.5% | -109.9% | -33.2% | -6.6% | -6.7% | -62.8% | -9.8% | -39.4% |
| Net Profit Margin | 37.4% | 61.1% | 9.0% | -1,029.7% | -1,984.5% | -267.0% | -10.3% | -391.8% | -913.4% | -135.0% | -546.5% |
| Debt to Equity | - | - | 0.16x | 0.43x | 0.58x | - | 1.11x | 0.01x | 0.00x | 0.00x | 0.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Akso Health Group ADR dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Aug 1, 2018
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 19.5M | 3.32 | 353.3% |
| 2018 | USD 19.5M | 3.69 | 29.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:3 on Aug 24, 2020.
Who owns Akso Health Group ADR
- Insiders 0.00%
- Institutions 0.02%
- Public & others 99.98%
- Shares outstanding 854M
- Free float 854M
Top funds holding AHG.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 15.0K | 0.00% | 0.00% | Aug 2026 |
Top institutions holding AHG.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Renaissance Technologies Corp | 70.9K | 0.01% | -27.90% | Jun 2026 |
| Northern Trust Corp | 51.4K | 0.01% | +9.66% | Jun 2026 |
| Citadel Advisors Llc | 46.0K | 0.01% | 0.00% | Jun 2026 |
| SmartHarvest Portfolios, LLC | 44.8K | 0.01% | +26.32% | Jun 2026 |
| Jane Street Group LLC | 41.4K | 0.00% | +32.41% | Jun 2026 |
| Geode Capital Management, LLC | 15.0K | 0.00% | 0.00% | Jun 2026 |
| BlackRock Inc | 10.1K | 0.00% | +27,100.00% | Jun 2026 |
| UBS Group AG | 963.00 | 0.00% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 739.00 | 0.00% | 0.00% | Jun 2026 |
| Huntington National Bank | 419.00 | 0.00% | 0.00% | Jun 2026 |
| Caitong International Asset Management Co., Limited. | 2.00 | 0.00% | 0.00% | Jun 2026 |
Akso Health Group ADR company profile
- Company name
- Akso Health Group ADR
- Ticker
- AHG.US
- Exchange
- USA Stocks
- Listed since
- Dec 28, 2006
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 12
- Fiscal year end
- March
- Address
- Qiantongyuan Building, Qingdao, China
- Phone
- 86 15 2100 54919
- Website
- ahgtop.com
About Akso Health Group ADR
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Akso Health Group ADR management
2- Ms. Yilin WangCEO & Chairwoman of the Board · born 1987
- Mr. Zhongliang XieChief Financial Officer · born 1972